REPORT ID 15962

Global Antidiabetic Biguanides Market Professional Survey Report 2017

Publish Date
30-Nov-17
Pages
115
Format
Electronic (PDF)

This report studies Antidiabetic Biguanides in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Pfizer
    AstraZeneca
    GlaxoSmithKline
    Merck & Co
    Eli Lilly
    Sanofi
    Takeda Pharmaceuticals
    Novo Nordisk
    Servier Laboratories
    Boehringer Ingelheim
    Bristol-Myers Squibb

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Metformin IR
    Metformin SR

By Application, the market can be split into
    Hospitals
    Clinics
    Other

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Antidiabetic Biguanides Market Professional Survey Report 2017
1 Industry Overview of Antidiabetic Biguanides
    1.1 Definition and Specifications of Antidiabetic Biguanides
        1.1.1 Definition of Antidiabetic Biguanides
        1.1.2 Specifications of Antidiabetic Biguanides
    1.2 Classification of Antidiabetic Biguanides
        1.2.1 Metformin IR
        1.2.2 Metformin SR
    1.3 Applications of Antidiabetic Biguanides
        1.3.1 Hospitals
        1.3.2 Clinics
        1.3.3 Other
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Antidiabetic Biguanides
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Antidiabetic Biguanides
    2.3 Manufacturing Process Analysis of Antidiabetic Biguanides
    2.4 Industry Chain Structure of Antidiabetic Biguanides

3 Technical Data and Manufacturing Plants Analysis of Antidiabetic Biguanides
    3.1 Capacity and Commercial Production Date of Global Antidiabetic Biguanides Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Antidiabetic Biguanides Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Antidiabetic Biguanides Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Antidiabetic Biguanides Major Manufacturers in 2016

4 Global Antidiabetic Biguanides Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Antidiabetic Biguanides Capacity and Growth Rate Analysis
        4.2.2 2016 Antidiabetic Biguanides Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Antidiabetic Biguanides Sales and Growth Rate Analysis
        4.3.2 2016 Antidiabetic Biguanides Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Antidiabetic Biguanides Sales Price
        4.4.2 2016 Antidiabetic Biguanides Sales Price Analysis (Company Segment)

5 Antidiabetic Biguanides Regional Market Analysis
    5.1 North America Antidiabetic Biguanides Market Analysis
        5.1.1 North America Antidiabetic Biguanides Market Overview
        5.1.2 North America 2012-2017E Antidiabetic Biguanides Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Antidiabetic Biguanides Sales Price Analysis
        5.1.4 North America 2016 Antidiabetic Biguanides Market Share Analysis
    5.2 China Antidiabetic Biguanides Market Analysis
        5.2.1 China Antidiabetic Biguanides Market Overview
        5.2.2 China 2012-2017E Antidiabetic Biguanides Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Antidiabetic Biguanides Sales Price Analysis
        5.2.4 China 2016 Antidiabetic Biguanides Market Share Analysis
    5.3 Europe Antidiabetic Biguanides Market Analysis
        5.3.1 Europe Antidiabetic Biguanides Market Overview
        5.3.2 Europe 2012-2017E Antidiabetic Biguanides Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Antidiabetic Biguanides Sales Price Analysis
        5.3.4 Europe 2016 Antidiabetic Biguanides Market Share Analysis
    5.4 Southeast Asia Antidiabetic Biguanides Market Analysis
        5.4.1 Southeast Asia Antidiabetic Biguanides Market Overview
        5.4.2 Southeast Asia 2012-2017E Antidiabetic Biguanides Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Antidiabetic Biguanides Sales Price Analysis
        5.4.4 Southeast Asia 2016 Antidiabetic Biguanides Market Share Analysis
    5.5 Japan Antidiabetic Biguanides Market Analysis
        5.5.1 Japan Antidiabetic Biguanides Market Overview
        5.5.2 Japan 2012-2017E Antidiabetic Biguanides Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Antidiabetic Biguanides Sales Price Analysis
        5.5.4 Japan 2016 Antidiabetic Biguanides Market Share Analysis
    5.6 India Antidiabetic Biguanides Market Analysis
        5.6.1 India Antidiabetic Biguanides Market Overview
        5.6.2 India 2012-2017E Antidiabetic Biguanides Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Antidiabetic Biguanides Sales Price Analysis
        5.6.4 India 2016 Antidiabetic Biguanides Market Share Analysis

6 Global 2012-2017E Antidiabetic Biguanides Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Antidiabetic Biguanides Sales by Type
    6.2 Different Types of Antidiabetic Biguanides Product Interview Price Analysis
    6.3 Different Types of Antidiabetic Biguanides Product Driving Factors Analysis
        6.3.1 Metformin IR of Antidiabetic Biguanides Growth Driving Factor Analysis
        6.3.2 Metformin SR of Antidiabetic Biguanides Growth Driving Factor Analysis

7 Global 2012-2017E Antidiabetic Biguanides Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Antidiabetic Biguanides Consumption by Application
    7.2 Different Application of Antidiabetic Biguanides Product Interview Price Analysis
    7.3 Different Application of Antidiabetic Biguanides Product Driving Factors Analysis
        7.3.1 Hospitals of Antidiabetic Biguanides Growth Driving Factor Analysis
        7.3.2 Clinics of Antidiabetic Biguanides Growth Driving Factor Analysis
        7.3.3 Other of Antidiabetic Biguanides Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Antidiabetic Biguanides
    8.1 Pfizer
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Pfizer 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Pfizer 2016 Antidiabetic Biguanides Business Region Distribution Analysis
    8.2 AstraZeneca
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 AstraZeneca 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 AstraZeneca 2016 Antidiabetic Biguanides Business Region Distribution Analysis
    8.3 GlaxoSmithKline
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 GlaxoSmithKline 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 GlaxoSmithKline 2016 Antidiabetic Biguanides Business Region Distribution Analysis
    8.4 Merck & Co
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Merck & Co 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Merck & Co 2016 Antidiabetic Biguanides Business Region Distribution Analysis
    8.5 Eli Lilly
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Eli Lilly 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Eli Lilly 2016 Antidiabetic Biguanides Business Region Distribution Analysis
    8.6 Sanofi
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Sanofi 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Sanofi 2016 Antidiabetic Biguanides Business Region Distribution Analysis
    8.7 Takeda Pharmaceuticals
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Takeda Pharmaceuticals 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Takeda Pharmaceuticals 2016 Antidiabetic Biguanides Business Region Distribution Analysis
    8.8 Novo Nordisk
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Novo Nordisk 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Novo Nordisk 2016 Antidiabetic Biguanides Business Region Distribution Analysis
    8.9 Servier Laboratories
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Servier Laboratories 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Servier Laboratories 2016 Antidiabetic Biguanides Business Region Distribution Analysis
    8.10 Boehringer Ingelheim
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Boehringer Ingelheim 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Boehringer Ingelheim 2016 Antidiabetic Biguanides Business Region Distribution Analysis
    8.11 Bristol-Myers Squibb

9 Development Trend of Analysis of Antidiabetic Biguanides Market
    9.1 Global Antidiabetic Biguanides Market Trend Analysis
        9.1.1 Global 2017-2022 Antidiabetic Biguanides Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Antidiabetic Biguanides Sales Price Forecast
    9.2 Antidiabetic Biguanides Regional Market Trend
        9.2.1 North America 2017-2022 Antidiabetic Biguanides Consumption Forecast
        9.2.2 China 2017-2022 Antidiabetic Biguanides Consumption Forecast
        9.2.3 Europe 2017-2022 Antidiabetic Biguanides Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Antidiabetic Biguanides Consumption Forecast
        9.2.5 Japan 2017-2022 Antidiabetic Biguanides Consumption Forecast
        9.2.6 India 2017-2022 Antidiabetic Biguanides Consumption Forecast
    9.3 Antidiabetic Biguanides Market Trend (Product Type)
    9.4 Antidiabetic Biguanides Market Trend (Application)

10 Antidiabetic Biguanides Marketing Type Analysis
    10.1 Antidiabetic Biguanides Regional Marketing Type Analysis
    10.2 Antidiabetic Biguanides International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Antidiabetic Biguanides by Region
    10.4 Antidiabetic Biguanides Supply Chain Analysis

11 Consumers Analysis of Antidiabetic Biguanides
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Antidiabetic Biguanides Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source